Drug profile · INN
fludrocortisone acetate
FLUDROCORTISONE ACETATE
fludrocortisone acetate (FLUDROCORTISONE ACETATE) is a mineralocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — fludrocortisone acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
fludrocortisone acetate (FLUDROCORTISONE ACETATE) is a mineralocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mineralocorticoid receptor agonist
Primary target: Mineralocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fludrocortisone acetate?
fludrocortisone acetate (FLUDROCORTISONE ACETATE) is a mineralocorticoid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fludrocortisone acetate?
FLUDROCORTISONE ACETATE is a marketed brand name for fludrocortisone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fludrocortisone acetate?
fludrocortisone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.